Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Idiopathic Pulmonary Fibrosis | 10 | 2023 | 505 | 3.270 |
Why?
|
| Myofibroblasts | 7 | 2022 | 116 | 1.540 |
Why?
|
| Indoles | 3 | 2017 | 306 | 1.000 |
Why?
|
| Uncoupling Protein 2 | 1 | 2022 | 8 | 0.830 |
Why?
|
| Lung | 9 | 2022 | 3546 | 0.790 |
Why?
|
| Energy Metabolism | 2 | 2023 | 729 | 0.710 |
Why?
|
| Pyridones | 2 | 2017 | 123 | 0.610 |
Why?
|
| Bone Marrow | 1 | 2019 | 244 | 0.610 |
Why?
|
| Pulmonary Fibrosis | 2 | 2019 | 322 | 0.570 |
Why?
|
| Aging | 2 | 2017 | 1620 | 0.560 |
Why?
|
| Fibrosis | 4 | 2023 | 453 | 0.530 |
Why?
|
| Mitochondria | 3 | 2018 | 751 | 0.530 |
Why?
|
| Metformin | 1 | 2018 | 277 | 0.480 |
Why?
|
| Transforming Growth Factor beta1 | 6 | 2020 | 153 | 0.460 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 347 | 0.430 |
Why?
|
| Restless Legs Syndrome | 2 | 2007 | 19 | 0.350 |
Why?
|
| Fibroblasts | 3 | 2022 | 838 | 0.350 |
Why?
|
| Fibronectins | 2 | 2020 | 108 | 0.300 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2007 | 53 | 0.270 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 3 | 2016 | 262 | 0.260 |
Why?
|
| Smad3 Protein | 2 | 2016 | 41 | 0.260 |
Why?
|
| Developing Countries | 1 | 2007 | 236 | 0.250 |
Why?
|
| Cells, Cultured | 4 | 2023 | 3890 | 0.250 |
Why?
|
| Oxidative Stress | 2 | 2022 | 1084 | 0.250 |
Why?
|
| Cellular Senescence | 1 | 2023 | 152 | 0.200 |
Why?
|
| Humans | 17 | 2023 | 114757 | 0.180 |
Why?
|
| Sirtuin 3 | 1 | 2021 | 52 | 0.180 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 536 | 0.170 |
Why?
|
| Peptide Hydrolases | 1 | 2020 | 105 | 0.170 |
Why?
|
| Interleukin-33 | 1 | 2019 | 38 | 0.170 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2016 | 52 | 0.160 |
Why?
|
| Adenylate Kinase | 1 | 2018 | 26 | 0.160 |
Why?
|
| Bone Marrow Cells | 1 | 2019 | 267 | 0.160 |
Why?
|
| Signal Transduction | 4 | 2019 | 4522 | 0.150 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2018 | 126 | 0.140 |
Why?
|
| RNA Interference | 2 | 2016 | 437 | 0.140 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2017 | 93 | 0.140 |
Why?
|
| Bleomycin | 1 | 2018 | 228 | 0.140 |
Why?
|
| Spheroids, Cellular | 1 | 2017 | 58 | 0.130 |
Why?
|
| Enzyme Activation | 1 | 2018 | 787 | 0.130 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2016 | 5 | 0.130 |
Why?
|
| Cell Movement | 1 | 2020 | 867 | 0.130 |
Why?
|
| Autophagy-Related Protein 7 | 1 | 2016 | 5 | 0.130 |
Why?
|
| Beclin-1 | 1 | 2016 | 9 | 0.130 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2016 | 59 | 0.130 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2016 | 13 | 0.130 |
Why?
|
| Cellular Reprogramming | 1 | 2016 | 84 | 0.130 |
Why?
|
| Drug Approval | 1 | 2016 | 78 | 0.130 |
Why?
|
| Collagen Type I | 1 | 2016 | 108 | 0.120 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2016 | 171 | 0.120 |
Why?
|
| Caveolin 1 | 1 | 2015 | 20 | 0.120 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 299 | 0.110 |
Why?
|
| Transfection | 1 | 2016 | 870 | 0.110 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 751 | 0.110 |
Why?
|
| Animals | 5 | 2022 | 31762 | 0.110 |
Why?
|
| Lung Injury | 1 | 2016 | 197 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 276 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 4710 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1846 | 0.100 |
Why?
|
| Phosphorylation | 1 | 2016 | 1571 | 0.100 |
Why?
|
| India | 2 | 2007 | 134 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2016 | 1022 | 0.080 |
Why?
|
| Mice | 2 | 2022 | 14916 | 0.080 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 3542 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2016 | 2557 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2015 | 1699 | 0.080 |
Why?
|
| Cell Proliferation | 1 | 2015 | 2196 | 0.070 |
Why?
|
| Protoporphyrins | 1 | 2007 | 17 | 0.070 |
Why?
|
| Menorrhagia | 1 | 2007 | 14 | 0.070 |
Why?
|
| Iron-Binding Proteins | 1 | 2007 | 38 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 2321 | 0.070 |
Why?
|
| Blood Donors | 1 | 2007 | 89 | 0.070 |
Why?
|
| Statistics as Topic | 1 | 2007 | 294 | 0.070 |
Why?
|
| Reference Values | 1 | 2007 | 742 | 0.060 |
Why?
|
| Time Factors | 1 | 2016 | 6124 | 0.060 |
Why?
|
| Urban Population | 1 | 2007 | 398 | 0.060 |
Why?
|
| Aged | 1 | 2022 | 19094 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2016 | 812 | 0.050 |
Why?
|
| Cell Line | 2 | 2020 | 2639 | 0.050 |
Why?
|
| Erythrocytes | 1 | 2007 | 591 | 0.050 |
Why?
|
| A549 Cells | 1 | 2020 | 51 | 0.040 |
Why?
|
| Peroxidase | 1 | 2020 | 157 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2007 | 4409 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 2539 | 0.040 |
Why?
|
| Disease Progression | 2 | 2017 | 2387 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 2020 | 181 | 0.040 |
Why?
|
| Tyrosine | 1 | 2020 | 215 | 0.040 |
Why?
|
| Male | 3 | 2018 | 55579 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 927 | 0.040 |
Why?
|
| Genes, Developmental | 1 | 2016 | 2 | 0.040 |
Why?
|
| Fibroblast Growth Factor 10 | 1 | 2016 | 24 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 435 | 0.030 |
Why?
|
| Gene Expression | 1 | 2021 | 1420 | 0.030 |
Why?
|
| Hedgehog Proteins | 1 | 2016 | 173 | 0.030 |
Why?
|
| Electron Transport | 1 | 2015 | 108 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 228 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2015 | 39 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 299 | 0.030 |
Why?
|
| Neutrophils | 1 | 2020 | 1163 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2016 | 596 | 0.030 |
Why?
|
| Glycolysis | 1 | 2015 | 227 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2016 | 589 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2020 | 2582 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2016 | 449 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2017 | 338 | 0.030 |
Why?
|
| Biopsy | 1 | 2017 | 1040 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2015 | 588 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1635 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 1021 | 0.020 |
Why?
|
| Middle Aged | 2 | 2007 | 26757 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 1521 | 0.020 |
Why?
|
| Female | 3 | 2020 | 59507 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2017 | 3005 | 0.020 |
Why?
|
| Models, Biological | 1 | 2017 | 1630 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 2763 | 0.020 |
Why?
|
| Adult | 2 | 2007 | 30548 | 0.020 |
Why?
|
| Research Design | 1 | 2007 | 931 | 0.010 |
Why?
|
| Prevalence | 1 | 2007 | 2249 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2007 | 4625 | 0.010 |
Why?
|